Roch-philippe J. Charles
Bern, BE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Pharmacodynamic analyses of LAT1 inhibitors in vitro and in vivo by targeted metabolomics reveal target-independent effects.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 17, 2025
Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial).
Journal: PLoS medicine
Published: August 16, 2024
A French regional survey of the role of general practitioners in the follow-up of patients with post-intensive-care syndrome (PICS).
Journal: Anaesthesia, critical care & pain medicine
Published: April 03, 2024
BRAFV600E Overrides NOTCH Signaling in Thyroid Cancer.
Journal: Thyroid : official journal of the American Thyroid Association
Published: October 05, 2020
SLC16 Family: From Atomic Structure to Human Disease.
Journal: Trends in biochemical sciences
Published: April 28, 2020
Care through cohort studies: sociological survey of the PROOF cohort study on vascular and cognitive aging.
Journal: Journal of public health (Oxford, England)
Published: May 13, 2019
Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.
Journal: Thyroid : official journal of the American Thyroid Association
Published: April 03, 2019
The L-Type Amino Acid Transporter LAT1-An Emerging Target in Cancer.
Journal: International journal of molecular sciences
Published: March 20, 2019
Identifying Lysophosphatidic Acid Acyltransferase β (LPAAT-β) as the Target of a Nanomolar Angiogenesis Inhibitor from a Phenotypic Screen Using the Polypharmacology Browser PPB2.
Journal: ChemMedChem
Published: August 16, 2018
MEK Inhibition Induces Therapeutic Iodine Uptake in a Murine Model of Anaplastic Thyroid Cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 27, 2018
The LAT1 inhibitor JPH203 reduces growth of thyroid carcinoma in a fully immunocompetent mouse model.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 29, 2018
Last Updated: 09/26/2026